MindBio Therapeutics Engages Market-Making Services to Support Trading of Its AI Voice Analytics Technology Shares

MindBio Therapeutics Corp., a biotechnology company developing AI-driven voice analytics for detecting drug and alcohol intoxication, has engaged Venture Liquidity Providers to provide market-making services for its common shares. The appointment, subject to regulatory and final approvals, aims to maintain an orderly trading market for the company’s stock on the Canadian Securities Exchange and other trading platforms where it is listed.

The market-making services will be conducted through W.D. Latimer Co. Ltd. in compliance with Canadian Securities Exchange policies. MindBio has agreed to pay $5,000 per month over a 12-month term for these services, though the arrangement may be terminated at any time. Both parties operate at arm’s length, with VLP holding no direct or indirect interest in MindBio or its securities.

This move comes as MindBio continues to commercialize its AI prediction technologies for intoxication detection through voice analysis. The company’s AI model uses over 50 million data points to predict alcohol intoxication with what it describes as remarkable accuracy using only the human voice. The technology represents a significant advancement in non-invasive intoxication detection methods that could have applications across multiple industries.

MindBio is developing an enterprise platform that includes Edge-AI kiosks integrating bespoke hardware and software for detecting drug and alcohol intoxication. These systems are designed for deployment in various enterprise environments including the mining industry, aviation, construction, and law enforcement. The company’s approach could potentially address safety concerns in workplaces where intoxication poses significant risks.

The market-making arrangement is particularly important for maintaining liquidity and orderly trading as MindBio advances its technology commercialization efforts. For investors seeking additional information about the company, updates relating to MBQIF are available through various financial news platforms. The full details of the market-making arrangement were outlined in the company’s official announcement which can be accessed through financial news distribution services.

Market-making services like those provided by Venture Liquidity Providers help ensure that there is consistent buying and selling activity for a company’s shares, which can reduce price volatility and improve market efficiency. For emerging biotechnology companies like MindBio, maintaining an orderly trading environment can be crucial as they navigate the capital markets while developing and commercializing innovative technologies.

This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is MindBio Therapeutics Engages Market-Making Services to Support Trading of Its AI Voice Analytics Technology Shares.

The post MindBio Therapeutics Engages Market-Making Services to Support Trading of Its AI Voice Analytics Technology Shares appeared first on citybuzz.